Physician profile
Darrell Wu
NPI 1598921272
$21,020.81
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,768 · 2020: $14.82 · 2021: $790 · 2022: $612 · 2023: $320 · 2024: $1,618 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $2,251 · Travel and Lodging: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,150.00 |
| Food and Beverage | $2,250.86 |
| Travel and Lodging | $1,435.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $14,575.39 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $2,956.88 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Sapien 3 Ultra Resilia |
| Artivion, INC. | $2,162.87 | 2019 | |
| Atricure, INC. | $450.27 | 2021-2024 | |
| Medtronic Vascular, INC. | $420.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $280.43 | 2022 | |
| Ethicon US, LLC | $82.06 | 2022-2024 | Prolene, Evarrest, Ethicon |
| Chiesi USA, INC. | $36.45 | 2022 | |
| Merck Sharp & Dohme LLC | $21.01 | 2024 | Bridion |
| Abbott Laboratories | $20.57 | 2022 | |
| Intuitive Surgical, INC. | $14.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.